| Issue Date | Title | Author(s) |
| 2019-04-03 | Stable maintenance of the rudivirus SIRV3 in a carrier state in Sulfolobus islandicus despite activation of the CRISPR-Cas immune response by a second virus SMV1 | Papathanasiou, P; Erdmann, S; Leon-Sobrino, C; Sharma, K; Urlaub, H; Garrett, RA; Peng, X |
| 2017-06-01 | Functional dissection of NEAT1 using genome editing reveals substantial localization of the NEAT1-1 isoform outside paraspeckles | Li, R; Harvey, AR; Hodgetts, SI; Fox, AH |
| 2022-04-22 | Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy. | Zou, Y; Sun, X; Yang, Q; Zheng, M; Shimoni, O; Ruan, W; Wang, Y; Zhang, D; Yin, J; Huang, X; Tao, W; Park, JB; Liang, X-J; Leong, KW; Shi, B |
| 2017-11-01 | Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh. | Naser, IB; Hoque, MM; Nahid, MA; Tareq, TM; Rocky, MK; Faruque, SM |
| 2021-10-01 | A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19. | Li, S; Huang, J; Ren, L; Jiang, W; Wang, M; Zhuang, L; Zheng, Q; Yang, R; Zeng, Y; Luu, LDW; Wang, Y; Tai, J |
| 2017-03-10 | Laser-mediated rupture of chlamydial inclusions triggers pathogen egress and host cell necrosis | Kerr, MC; Gomez, GA; Ferguson, C; Tanzer, MC; Murphy, JM; Yap, AS; Parton, RG; Huston, WM; Teasdale, RD |
| 2017-03-09 | CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: A path to clinical success? | Gerace, D; Martiniello-Wilks, R; Nassif, NT; Lal, S; Steptoe, R; Simpson, AM |
| 2022-04-22 | Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy. | Zou, Y; Sun, X; Yang, Q; Zheng, M; Shimoni, O; Ruan, W; Wang, Y; Zhang, D; Yin, J; Huang, X; Tao, W; Park, JB; Liang, X-J; Leong, KW; Shi, B |
